Lung cancer staging and the home insurance building constructed in 1884-1885

Chest

Volumn 136, Issue 1, 2009, Pages 6-8

  Colice, Gene ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

ARCHITECTURE; ASPIRATION BIOPSY; BUILDING; CANCER CLASSIFICATION; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HEALTH INSURANCE; HUMAN; LUNG NON SMALL CELL CANCER; METASTASIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 67650835173     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0797     Document Type: Editorial

References (13)

1. Salig P, ed. The sky's the limit. New York, NY: Rizzoli, 1990
2. Detterbeck F, Tanoue L, Boffa D. The new lung cancer staging system. Chest 2009; 136:260-271
3. Feinstein A. A new staging system for cancer and reappraisal of"early" treatment and "cure" by radical surgery. N Engl J Med 1968; 279:747-753
4. Hooper RG, Beechler CR, Johnson MC. Radioisotope scanning in the initial staging of bronchogenic carcinoma. Am Rev Respir Dis 1978; 118:279-286
5. Silvestri GA, Lenz JE, Harper SN, et al. The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma. Chest 1992; 102:1748-1751
6. Silvestri GA, Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cancer. Am J Respir Crit Care Med 1995; 152:225-230
7. Silvestri GA, Bould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer. Chest 2007; 132(suppl): 178S-201S
8. Wallace MB, Block M, Hoffman BJ, et al. Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. Am J Respir Crit Care Med 2003; 167:1670-1675
9. Mohamed S, Yasufuku K, Nakajima T, et al. Analysis of cell cycle-related proteins in mediastinal lymph nodes of patients with N2-NSCLC obtained by EBUS-TBNA: relevance to chemotherapy response. Thorax 2008; 63:642-647
10. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008; 359:1367-1380
11. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007; 356:11-20
12. Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008; 359:366-377
13. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89(suppl):225S-233S